Debut of Riskguard™ Hereditary Cancer Test by Exact Sciences in the United States

Today, Exact Sciences Corp., renowned for its cancer screening and diagnostic solutions, unveiled the introduction of the Riskguard™ hereditary cancer test across the United States. This innovative test furnishes personalized patient reports detailing gene-specific and familial risks for 10 prevalent…

Read MoreDebut of Riskguard™ Hereditary Cancer Test by Exact Sciences in the United States

Oticon Launches Oticon Intent: First Hearing Aid with User-Intent Sensors

Today, Oticon, Inc. introduces Oticon Intent™, the world’s pioneering hearing aid featuring user-intent sensors designed to comprehend and adjust to individuals’ preferences in challenging listening environments. With its innovative technology, Oticon Intent aims to enhance the engagement of people with…

Read MoreOticon Launches Oticon Intent: First Hearing Aid with User-Intent Sensors

CAP Enhances Immunohistochemical Assay Validation Guideline for Better Patient Care

The College of American Pathologists (CAP) updated the “Principles of Analytic Validation of Immunohistochemical Assays” guideline to provide increased precision and accuracy of clinical immunohistochemical assays. This update assesses evidence published since the release of the original guideline in 2014…

Read MoreCAP Enhances Immunohistochemical Assay Validation Guideline for Better Patient Care